指南与共识皮肤肿瘤皮肤感染自身免疫性与大疱性皮肤病

皮肤病理学适当使用标准:美国皮肤病理学会初步推荐

Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology.
指南 / 共识 · J Am Acad Dermatol · 2018-04-22

美国皮肤病理学会联合美国皮肤病学会和美国病理学家学会,采用RAND/UCLA适当性方法制定皮肤病理学适当使用标准,针对12项辅助检查的211个临床场景,188个(89%)达成共识,其中93个(44%)为「通常适当」,52个(25%)为「极少适当」,43个(20%)为「适当性不确定」。

要点

  • 针对12项皮肤病理辅助检查的211个临床场景制定了适当使用标准。
  • 188个(89%)场景达成共识,93个(44%)为「通常适当」,52个(25%)为「极少适当」。
  • 43个(20%)场景为「适当性不确定」,未达成共识的场景可能受益于进一步研究。

核心结论

  • 特定检查的最终决定权在医生,且预期获益应超过负面后果。
  • 本文概述了皮肤病理学中12项检查的适当使用标准推荐。
  • 这些推荐可能随新证据而改变,被判定为「适当性不确定」及未达成共识的结果可能受益于进一步研究。

研究设计与样本

  • 美国皮肤病理学会在美国皮肤病学会和美国病理学家学会参与下,采用RAND/UCLA适当性方法制定皮肤病理学适当使用标准。
  • 该方法结合循证医学、临床经验和专家判断,评级次数预先设定为3次。

主要发现

  • 针对涉及12项辅助检查的211个临床场景制定了适当使用标准。
  • 188个(89%)临床场景达成共识,其中93个(44%)被认为「通常适当」,52个(25%)为「极少适当」,43个(20%)为「适当性不确定」。

关键数值与推荐

  • 211个临床场景中188个(89%)达成共识,93个(44%)为「通常适当」,52个(25%)为「极少适当」,43个(20%)为「适当性不确定」。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该方法要求聚焦适当性,不进行检验间比较,也不考虑成本。
  • 这些推荐可能随新证据而改变。
  • 被判定为「适当性不确定」及未达成共识的结果可能受益于进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making. OBJECTIVES: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology. METHODS: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience, and expert judgment, was used to develop AUC in dermatopathology. RESULTS: With the number of ratings predetermined at 3, AUC were developed for 211 clinical scenarios involving 12 ancillary studies. Consensus was reached for 188 (89%) clinical scenarios, with 93 (44%) considered "usually appropriate" and 52 (25%) "rarely appropriate" and 43 (20%) having "uncertain appropriateness." LIMITATIONS: The methodology requires a focus on appropriateness without comparison between tests and irrespective of cost. CONCLUSIONS: The ultimate decision to order specific tests rests with the physician and is one where the expected benefit exceeds the negative consequences. This publication outlines the recommendations of appropriateness-the AUC for 12 tests used in dermatopathology. Importantly, these recommendations may change considering new evidence. Results deemed "uncertain appropriateness" and where consensus was not reached may benefit from further research.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Vidal CI, Armbrect EA, Andea AA, et al. Appropriate use criteria in dermatopathology: Initial recommendations from the American Society of Dermatopathology. J Am Acad Dermatol. 2018. PMID: 29689323. doi:10.1016/j.jaad.2018.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。